Long-term outcome in pyridoxine-dependent epilepsy

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Pyridoxine-dependent epilepsy (PDE) is a rare genetic disorder requiring prompt treatment.
• Understanding the long-term outcomes and factors influencing neurodevelopment in PDE is crucial for improving patient care.

Purpose of the Study:

• To retrospectively investigate the long-term outcomes of a Dutch cohort with pyridoxine-dependent epilepsy.
• To identify correlations between patient characteristics and follow-up data, including neurodevelopmental and neuroimaging assessments.

Main Methods:

• Retrospective study of 14 PDE patients from a national reference laboratory.
• Data collected included demographics, age at seizure onset and pyridoxine initiation, urinary alpha-aminoadipic semialdehyde levels, antiquitin mutations, developmental milestones, neurocognitive function, school career, MRI, and EEG.

Main Results:

• Most patients experienced delayed mental development (median IQ 72).
• Pyridoxine monotherapy controlled seizures in 10/14 patients; four required additional antiepileptic drugs.
• Delayed pyridoxine initiation and corpus callosum abnormalities were associated with poor neurodevelopmental outcomes.

Conclusions:

• The long-term outcome for patients with pyridoxine-dependent epilepsy is generally poor.
• Current patient characteristics do not reliably predict individual outcomes.
• Collaborative research in structured settings is recommended to enhance treatment strategies and improve outcomes for PDE.